首页> 外文期刊>Cardiovascular Endocrinology & Metabolism >Acute cardiac overload does not induce cardiac or skeletal expression of fibroblast growth factor 23 in rats
【24h】

Acute cardiac overload does not induce cardiac or skeletal expression of fibroblast growth factor 23 in rats

机译:

获取原文
获取原文并翻译 | 示例

摘要

Objective Elevated fibroblast growth factor 23 (FGF23) is associated with cardiovascular events, particularly heart failure. Although FGF23 has been reported to induce cardiac hypertrophy, recent studies demonstrated that cardiac hypertrophy and myocardial infarction induce FGF23 production by cardiomyocytes. We aimed to explore whether acute cardiac overload increases cardiac and skeletal FGF23 expression and circulating FGF23 levels. Methods We administered 30 μL/g bodyweight of isotonic saline intraperitoneally in rats to induce acute cardiac overload. We measured serum FGF23 levels and other parameters of mineral metabolism at 2, 6, and 24 h after saline or sham injection. We also analyzed gene expression in the heart, calvarium, femur, and kidney at 2 and 24 h after injection. Results Acute saline injection induced cardiac overload as evidenced by a significant upregulation of brain natriuretic peptide along with a trend towards increased expression of atrial natriuretic peptide and mild hyponatremia. However, there were no changes in serum FGF23 levels or FGF23 expression in the heart, calvarium, or femur. Conclusions Acute cardiac overload by saline injection in rats did neither induce FGF23 expression in the heart or bone nor did it increase serum FGF23 levels. These findings suggest that more severe or long-term cardiac damage is required for induction of FGF23 expression.

著录项

  • 来源
    《Cardiovascular Endocrinology & Metabolism》 |2021年第4期|204-209|共6页
  • 作者单位

    Division of Nephrology, Endocrinology and Metabolism;

    Interactive Translational Research Center for Kidney Diseases, Tokai University School of Medicine;

    The Institute of Medical Sciences, Tokai University, Isehara, Japan;

    Received 1 December 2020 Accepted 5 March 2021;

    Correspondence to Hirotaka Komaba, MD, PhD, Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, 143 Shimo-Kasuya, Isehara 259-1193, Japan, E-mail:;

    This is an open access article distributed under the;

    , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号